Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'

Detalles Bibliográficos
Autores principales: Imafuku, Keisuke, Yoshino, Koji, Yamaguchi, Kei, Tsuboi, Satoshi, Ohara, Kuniaki, Hata, Hiroo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396113/
https://www.ncbi.nlm.nih.gov/pubmed/28324884
http://dx.doi.org/10.1038/bjc.2017.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396113/
https://www.ncbi.nlm.nih.gov/pubmed/28324884
http://dx.doi.org/10.1038/bjc.2017.58

Ejemplares similares